Liver Diseases  >>  zibotentan (ZD4054)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zibotentan (ZD4054) / AstraZeneca
NCT00672581: Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic Impairment

Completed
1
32
Europe
ZD4054, Zibotentan
AstraZeneca, PRA Health Sciences
Hepatic Impairment
 
03/09

Download Options